Exelixis, Inc. (NASDAQ:EXEL) Receives Consensus Rating of "Moderate Buy" from Analysts

Retrieved on: 2022-12-28 06:26:09

Tags for this article:

Finance

Economy

Click the tags to see associated articles and topics

Exelixis, Inc. (NASDAQ:EXEL) Receives Consensus Rating of "Moderate Buy" from Analysts. View article details on HISWAI: https://www.marketbeat.com/instant-alerts/nasdaq-exel-consensus-analyst-rating-2022-12-2-3/

Excerpt

Renaissance Technologies LLC now owns 17,783,937 shares of the biotechnology company's stock valued at $370,262,000 after purchasing an additional ...

Article found on: www.marketbeat.com

View Original Article